{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:08:32Z","timestamp":1762506512559,"version":"3.41.2"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"vor","delay-in-days":672,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Validated skin testing is lacking for many drugs, including ceftaroline. The cross-reactivity between ceftaroline and other \u03b2-lactam antibiotics is unknown. We report a case of a pregnant patient with cystic fibrosis and multiple drug allergies who required ceftaroline for methicillin-resistant Staphylococcus aureus pneumonia and underwent an uncomplicated empiric desensitization procedure.<\/jats:p>","DOI":"10.1093\/ofid\/ofv027","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T02:03:24Z","timestamp":1425521004000},"source":"Crossref","is-referenced-by-count":4,"title":["Ceftaroline Desensitization Procedure in a Pregnant Patient With Multiple Drug Allergies"],"prefix":"10.1093","volume":"2","author":[{"suffix":"Jr","given":"James L.","family":"Kuhlen","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital"},{"name":"Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital"},{"name":"Harvard Medical School"},{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline L.","family":"Sokol","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital"},{"name":"Harvard Medical School"},{"name":"Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana S.","family":"Balekian","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital"},{"name":"Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana A.","family":"Weil","sequence":"additional","affiliation":[{"name":"Harvard Medical School"},{"name":"Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christy A.","family":"Varughese","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital"},{"name":"Department of Pharmacy, Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica S.","family":"Shenoy","sequence":"additional","affiliation":[{"name":"Harvard Medical School"},{"name":"Medical Practice Evaluation Center, Massachusetts General Hospital"},{"name":"Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital"},{"name":"Infection Control Unit, Massachusetts General Hospital, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital"},{"name":"Harvard Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"key":"2020081006471102500_OFV027C1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2020081006471102500_OFV027C2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/ajhp\/58.14.1317","article-title":"Potential risks and prevention, part 1: fatal adverse drug events","volume":"58","author":"Kelly","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"2020081006471102500_OFV027C3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2004.08.002","article-title":"Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions","volume":"95","author":"Lee","year":"2004","journal-title":"Gynecol Oncol"},{"key":"2020081006471102500_OFV027C4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra993637","article-title":"Cephalosporin allergy","volume":"345","author":"Kelkar","year":"2001","journal-title":"N Engl J Med"},{"key":"2020081006471102500_OFV027C5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2020081006471102500_OFV027C6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2500\/aap.2014.35.3739","article-title":"Evaluation and management of a patient with multiple drug allergies","volume":"35","author":"Blumenthal","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"2020081006471102500_OFV027C7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaip.2014.08.001","article-title":"Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review","volume":"2","author":"Iammatteo","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2020081006471102500_OFV027C8","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2009.02.042","article-title":"Risk str.jpegication for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management","volume":"123","author":"Hesterberg","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2020081006471102500_OFV027C9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"(Suppl 3)","key":"2020081006471102500_OFV027C10","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1093\/cid\/cis559","article-title":"Summary of ceftaroline fosamil clinical trial studies and clinical safety","volume":"55","author":"File","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020081006471102500_OFV027C11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1179\/1973947813Y.0000000156","article-title":"Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients","volume":"27","author":"Pasquale","year":"2015","journal-title":"J Chemother"},{"article-title":"TEFLARO\u00ae (ceftaroline fosamil) injection for intravenous (IV) use","year":"2010","author":"Laboratories F","key":"2020081006471102500_OFV027C12"},{"key":"2020081006471102500_OFV027C13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diagmicrobio.2014.11.016","article-title":"Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA","volume":"81","author":"Stryjewski","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020081006471102500_OFV027C14","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/AAC.02371-13","article-title":"Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy","volume":"58","author":"Casapao","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081006471102500_OFV027C15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2146\/ajhp140151","article-title":"Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions","volume":"72","author":"Jones","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"2020081006471102500_OFV027C16","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jaci.2004.03.023","article-title":"Safety of cephalosporin administration to patients with histories of penicillin allergy","volume":"113","author":"Daulat","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2020081006471102500_OFV027C17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1542\/peds.2004-1276","article-title":"A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients","volume":"115","author":"Pichichero","year":"2005","journal-title":"Pediatrics"},{"key":"2020081006471102500_OFV027C18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.anai.2014.02.005","article-title":"Penicillin and cephalosporin allergy","volume":"112","author":"Pichichero","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2020081006471102500_OFV027C19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0002-9378(89)90766-7","article-title":"Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant?","volume":"161","author":"Reyes","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"(5 Pt 2)","key":"2020081006471102500_OFV027C20","first-page":"908","article-title":"Transplacental passage of vancomycin during the second trimester of pregnancy","volume":"78","author":"Bourget","year":"1991","journal-title":"Obstet Gynecol"},{"key":"2020081006471102500_OFV027C21","first-page":"93","article-title":"Vancomycin in pregnancy","volume":"93","author":"MacCulloch","year":"1981","journal-title":"N Z Med J"},{"issue":"(RR\u201310)","key":"2020081006471102500_OFV027C22","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2020081006471102500_OFV027C23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/AOG.0b013e318219229b","article-title":"ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns","volume":"117","year":"2011","journal-title":"Obstet Gynecol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/1\/ofv027\/33621374\/ofv027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/1\/ofv027\/33621374\/ofv027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T10:51:03Z","timestamp":1597056663000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofv027\/2337976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofv027","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2015]]},"published":{"date-parts":[[2015,1,1]]},"article-number":"ofv027"}}